September 9, 2024

Data from Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain

View Full Paper

Ask AI

Bookmark

Engineering cell-intrinsic signaling via an IL7R domain preserves canonical downstream activation and antitumor cytotoxicity without requiring exogenous cytokine support.
Evaluation of acute myeloid leukemia cells shows that coexpressing a chimeric cytokine receptor with a cytotoxic CAR maintains membrane proximity critical for activation.
Preclinical cell model findings suggest chimeric antigen receptor designs with intrinsic cytokine support may improve T-cell persistence in leukemia immunotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Preclinical study demonstrates cell-intrinsic IL7R signaling in CAR T cells, suggesting enhanced persistence and antitumor activity against acute myeloid leukemia.

Cite This Study

Vorri et al. (2024) studied this question.

synapsesocial.com/papers/68e590e9b6db64358752c249 https://doi.org/10.1158/2767-9764.c.7439354

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study demonstrates cell-intrinsic IL7R signaling in CAR T cells, suggesting enhanced persistence and antitumor activity against acute myeloid leukemia.

Data from Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain

Key Points

Discussion

Implication

Cite This Study

Data from Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider